UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
(Check one): oForm 10-K oForm 20-F oForm 11-K X Form 10-Q o Form N-SAR oForm N-CSR
For Period Ended: June 30, 2017
oTransition Report on Form 10-K
oTransition Report on Form 20-F
oTransition Report on Form 11-K
oTransition Report on Form 10-Q
oTransition Report on Form N-SAR
For the Transition Period Ended:
Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.
If the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:
PART I -- REGISTRANT INFORMATION
MJ Biotech, Inc.
Full Name of Registrant
Michael James Enterprises, Inc.
Former Name if Applicable
760 Route 10 West, Suite 203
Address of Principal Executive Office (Street and Number)
Whippany, New Jersey 07981
City, State and Zip Code
PART II -- RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)
x | (a) | The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; |
|
|
|
x | (b) | The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and |
|
|
|
| (c) | The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. |
|
|
|
PART III -- NARRATIVE
State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.
The Registrant requires additional time to complete the Quarterly Report on Form 10Q because of the limited resources of the company it can not retain the additional accounting and financial personnel required to complete the Report in a timely manner and is unable to pay additional fees in order to expedite the audit or review of same.
PART IV -- OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this notification
Maxine Pierson | (908) | 204-0004 |
(Name) | (Area Code) | (Telephone Number) |
(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). Yes x Noo
(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
Yes o No x
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
MJ Biotech, Inc.
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
| |
|
|
|
Dated: August 15, 2017 | By: | /s/ Maxine Pierson |
|
| |
| Maxine Pierson / C.E.O. | |
